Conclusion: The presence of CHB is associated with a reduced diagnostic performance of the FIB-4 index in patients with MASLD
When compared with time periods in which other second-line antidiabetic medications were used, semaglutide and liraglutide use periods were also associated with a significantly better outcome
134979-01-4, CH2COOH-PEG2-NH2.HCl References: [1] Tan, Q., Akindehin, S
Disclosures: Benjamin Laevens: Nothing to Disclose, Yazhou Chen: Nothing to Disclose, Jan Clusmann: Nothing to Disclose, Niharika Jakhar: Nothing to Disclose, Thriveni Raju: Nothing to Disclose, Tobias Seibel: Nothing to Disclose, Kai Markus Schneider: Nothing to Disclose, Carolin Victoria Schneider: Nothing to Disclose 847 DEEP LEARNING CAN PREDICT MASLD-RELATED GENETIC RISK VARIANTS FROM LIVER MAGNETIC RESONANCE IMAGING Yazhou Chen 1 Benjamin Laevens 1 Teresa Lemainque 1 Gustav Mller-Franzes 1 Tobias Seibel 1 Carola Dlugosch 1 Jan Clusmann 1 Paul-Henry Koop 1 Thriveni Raju 1 Niharika Jakhar 1 Rongpeng Gong 1 Simon Schophaus 1 Kai Markus Schneider 1 Daniel Truhn 1 Carolin Victoria Schneider 1 , 1 University Hospital Aachen Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has become the most common chronic liver disease and a major threat to global health
M.ReimannF.TrappS
& Retnakaran, R